update Updates

On Eve of JPML Decision, a Closer Look at Darvocet Lawsuit MDL

With an announcement due any day now about whether multidistrict litigation (MDL) will be granted for all federal Darvon and Darvocet lawsuits it is worth taking a closer look at the MDL procedure and the panel of judges that oversees it. As the Rottenstein Law Group has previously written MDL… Read more

Darvocet Lawsuit MDL Hearing Set to Begin Wednesday, March 30

On Wednesday March 30 the Judicial Panel on Multidistrict Litigation (JPML) will hear arguments about whether all Darvon and Darvocet lawsuits should be centralized for pretrial litigation before a single federal judge. Last December the attorneys representing Queens New York resident Kristine Esposito filed a petition requesting multi district… Read more

What Propoxyphene Manufacturers Knew… and the Effect on Darvocet Lawsuits

Darvon and Darvocet lawsuits are one of the biggest legal stories of the day with some attorneys expecting settlements to be even larger than the record-setting $4.85 billion paid to settle Vioxx cases in 2007. But ever since the U.S. Food and Drug Administration (FDA) ordered the withdrawal of all products containing propoxyphene (the drug… Read more

Why You Need a Darvocet Attorney to Assist You With Your Claim

Since the U.S. Food and Drug Administration (FDA) issued a recall of the pain reliever propoxyphene last November lawsuits have continued to pile up against Xanodyne Pharmaceuticals Inc. the company that distributes Darvon and Darvocet. The FDA’s action was spurred by data that indicates propoxyphene can disrupt the heart’s normal rhythm … Read more

Cardiac Injuries Prompt Louisiana Residents to File Darvocet Lawsuit

Three Louisiana residents filed a Darvocet lawsuit recently against several drug manufacturers claiming that the painkiller caused them to suffer cardiac injuries. On March 4 Billy Lambert Gladys Delaune and Margaret Seagraves filed suit in U.S. District Court for the Eastern District of Louisiana. The complaint names several defendants… Read more

Supreme Court Decision, Obama Policies Affect Darvocet Lawsuits

The decision by the U.S. Food and Drug Administration (FDA) last November to recall all products containing the drug propoxyphene has led to numerous Darvon and Darvocet lawsuits being filed in state and federal courts. As they are currently interpreted under President Obama state tort laws allow an individual harmed by corporate irresponsibility to sue… Read more

Can I File a Darvocet Lawsuit Against an Acetaminophen Manufacturer?

Ever since the FDA recalled the painkiller propoxyphene last November Darvon and Darvocet lawsuits have continued to pile up against Xanodyne Pharmaceuticals Inc. the company that distributes the two products. While the sole active ingredient in Darvon is propoxyphene Darvocet additionally contains acetaminophen (better known by its brand name Tylenol). Because… Read more

Could Darvocet Lawsuits Push Xanodyne Pharmaceuticals to Insolvency?

As Darvon and Darvocet lawsuits continue to be filed against Xanodyne Pharmaceuticals Inc. there are signs that the cost of defending legal charges may push the company into economic ruin. Xanodyne founded in 2001 and headquartered in Newport Kentucky acquired Darvon and Darvocet from AAIPharma Inc. of Wilmington… Read more

Swedish Doctor Warned FDA of Darvon/Darvocet Side Effects in 1999

Years before the November 2010 FDA recall of the drug propoxyphene that led to the proliferation of Darvon and Darvocet lawsuits a Swedish physician was warning of the dangers of propoxyphene products calling them “the worst drugs ever.” That same doctor also believes that Darvocet litigation could become bigger than Vioxx … Read more

Physician Weighs in on FDA Action That Prompted Darvocet Lawsuits

A professor of neurology at Albany Medical College recently discussed the FDA action that led to the current wave of Darvon and Darvocet lawsuits. Dr. Charles Argoff the Director of the Comprehensive Pain Center at Albany Medical Center in Albany New York posted a video statement on Medscape.com about… Read more

Despite Prevalence of Darvocet Lawsuits, Group Fears Some Still Using Drug

The consumer advocacy group US Drug Watchdog issued a statement recently expressing the importance of identifying all individuals who used Darvon Darvocet or another painkiller containing the pain reliever propoxyphene and recently suffered a heart attack or had a pacemaker installed. Additionally the group said that it was concerned that a large… Read more

Darvocet Lawsuits Illustrate Debate Over FDA Effectiveness

As the Darvon and Darvocet lawsuits against Xanodyne Pharmaceuticals unfold they draw into focus the debate over how well United States public health is protected by its regulatory agencies. On the one hand it was new powers given to the Food and Drug Administration (FDA) that allowed it to order Xanodyne (the company that… Read more

Wrongful Death Darvocet Lawsuit Filed by Cincinnati Family

Cincinatti.com reported on Sunday about a wrongful death Darvocet lawsuit filed by the parents of a 22-year old woman who died suddenly after she had been taking the painkiller for eight days. Tammy and John Gilbert filed a wrongful death suit January 7 2011 against Xanodyne Pharmaceuticals Inc. the company that… Read more

Darvocet Lawsuits Focus on Drug’s Danger, But Many Depended on It for Pain Relief

While the Darvon and Darvocet lawsuits filed in response to the Food and Drug Administration (FDA)’s recall of the painkiller propoxyphene have the potential to be one of the biggest legal and health stories of 2011 it’s sometimes overlooked that millions of pain-sufferers depended on the drug for relief and now must consider alternative… Read more

In Run-Up to Darvocet Lawsuits, Physicians Express Concerns About Drug

Propoxyphene an opioid painkiller that is the active ingredient in Darvon and is combined with another pain reliever acetaminophen in Darvocet was recalled by the FDA in November due to its risk of cardiac side effects. The ability of the drug to cause fatal arrhythmias was confirmed in a study conducted… Read more

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.